HTAi Review | August 25, 2023

Your biweekly news source for all things Health Technology Assessment international

Breaking News 

Apply for the Jill Sanders Memorial Scholarship!

The Jill Sanders Memorial scholarship is offered in memory of Dr. Jill Sanders, former Vice President of HTAi and President and CEO of the Canadian Agency for Drugs and Technologies in Health.  

Dr. Sanders was a long-time champion of international collaboration in Health Technology Assessment (HTA). She was deeply committed to building HTA capacity in developing countries and to mentoring students and professionals. The Jill Sanders Memorial Scholarship provides funding for individuals residing in African countries to further their knowledge of HTA. The program objective is to have a positive impact on HTA capacity in African countries through developing professional HTA capacity. 

The Health Technology Assessment international (HTAi) Jill Sanders Memorial Scholarship provides funding support for individuals studying or working in the healthcare field in African countries to advance their knowledge and skills directly related to health technology assessment (HTA).  

By providing financial assistance to complete education programs or training in health technology assessment for the purpose of applying their knowledge and skills in their country of origin, HTAi advances its mission of promoting the development, communication, understanding, and use of HTA around the world. 

A total of $20,000 CAD is available for the HTAi Educational Scholarship program each fiscal year. Scholarship applications are due October 15 of each year (unless otherwise specified).


Reviewers Wanted: The International Journal of Technology Assessment in Health Care

International Journal of Technology Assessment in Health Care (IJTAHC) serves as a forum for the wide range of health policy makers and professionals interested in the economic, social, ethical, medical and public health implications of health technology. It covers the development, evaluation, diffusion and use of health technology, as well as its impact on the organization and management of health care systems and public health. In addition to general essays and research reports, regular columns on technology assessment reports and thematic sections are published.

IJTAHC is seeking reviewers with expertise in areas within the scope of IJTAHC relating to health technology assessment including systematic review, health economic evaluation, patient/citizen issues and health policy. Participating as an IJTAHC Reviewer is not only beneficial for your career development, it is a great way to contribute to the global HTA community!

Reviewer categories include:

  • Systematic reviews
  • Health economics/economic evaluation, CBA/CEA/CUA
  • Meta-analysis
  • Modelling
  • Clinical epidemiology
  • Clinical practice guidelines
  • Decision analysis
  • Patient/citizen issues
  • Personalized medicine
  • Pharmaceutical policy
  • Diagnostics
  • Disinvestment
  • E-health
  • Safety
  • Screening
  • Health outcomes research; health services/systems research
  • Health policy/policy analysis/social policy
  • Horizon scanning, new and emerging technologies
  • Statistics
  • Qualitative methodologies/questionnaires and surveys
  • Preventative medicine/public health/international health

If you are interested in becoming a reviewer for IJTAHC, please send an email to Wendy Babidge, Editor in Chief, and include short CV outlining areas of expertise relative to the reviewer categories.

A Look Back

HTAi 2023 Latin America Policy Forum

The 2023 Latin America Policy Forum (LATAM) took place August 13-15 in Santiago, Chile. Thank you to the Latin America Policy Forum Chair, Manuel Antonio Espinoza; and Scientific Secretary, Andrés Pichon-Riviere; and Administrative Support, Valentina Stacco,  for their many contributions to the Forum’s success!

Click the button below to take a look at the LATAM 2023 Background Paper.

HTAi 2023 Annual Meeting updates

The 2023 Annual Meeting may have ended, but we are still thinking about all of the great memories made in Adelaide… and so can you! Visit to take a look through the event photo album and relive your favourite moments, or download your pictures to share on social media platforms (don’t forget to tag us)!

Also available: the 2023 Annual Meeting Oral and Poster Abstract Books, featuring every Oral and Poster presentation from the five-day conference. 

Network News

The 11th HTAsiaLink Conference 2023 is scheduled to take place September 4 – 7 in Putrajaya, Malaysia. The conference theme is “Reshaping and Reshifting Health Technology Assessment in Navigating the future Landscape.”

HTAi representatives will be attending the Conference on behalf of the organization. Learn more

Priorities 2024 Conference
Submissions for the 2024 Priorities Conference in Bangkok, Thailand, hosted by HiTAP and the Ministry of Public Health, Thailand, are now open for Organized Sessions, Workshops, Oral, and Poster submissions. Learn more

HTA News from Around the World

From Australia’s Department of Health and Aged Care: The Department of Health and Aged Care is seeking expressions of interest from suitably qualified and experienced individuals who would like to be considered for upcoming vacancies on national health technology assessment (HTA) committees and associated subcommittees. Read more

From CADTH: CADTH is establishing an industry task force to provide advice on the use of industry-generated real-world data (RWD) in its Post-Market Drug Evaluation (PMDE) Program. Read more

From EUnetHTA: The EUnetHTA 21 Consortium will cease operations on 16 September 2023. Read more

From the Bulletin Board

If you have an open position you’d like to share with the HTAi membership, please contact [email protected].

IJTAHC Featured Publications

  • Do France, Germany, and Italy agree on the added therapeutic value of medicines? Read more
  • Patient and citizen participation at the organizational level in health technology assessment: an exploratory study in five jurisdictions. Read more
  •  Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group. Read more

Important Upcoming Dates

Views Navigation

Event Views Navigation